The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trial
ConclusionIn CKD patients with dyslipidemia, hyperuricemia was an independent risk factor for CKD progression. An ongoing clinical trial (TARGET-UA, UMIN-ID 000,026,741) may reveal the significance of strict UA-lowering therapy in CKD patients.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Atorvastatin Calcium | Chronic Kidney Disease | Clinical Trials | Japan Health | Lipitor | Statin Therapy | Urology & Nephrology | Zivast